Study of adults with pulmonary Langerhans cell histiocytosis
Part of Blood & lymphatic, Lungs & breathing clinical trials.
This study follows adults with a specific lung condition to better understand how it behaves over time. If you have the right diagnosis, joining could help researchers learn what to expect and how to manage it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have pulmonary Langerhans cell histiocytosis (PLCH)
- Your PLCH diagnosis was confirmed by biopsy OR by a clinician’s diagnosis using symptoms, typical lung scan findings, and ruling out other causes
- You have had a high-resolution CT (HRCT) scan of your lungs showing the typical nodule-and-cyst pattern (if not biopsy-confirmed)
- There are no stated exclusion conditions in the eligibility list provided
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for adults with Langerhans cell histiocytosis (LCH) and also for adults with certain lung conditions (like cystic lung disease or emphysema) or healthy smokers to act as controls. The goal is to find biomarkers (signs in the body) that can help doctors diagnose LCH, predict how it will progress, and see how well treatment is working.
This study is checking in over time with people who have a histiocytic disorder. It may help doctors better understand how these conditions behave and what follow-up care works best.
This study enrolls adults with chronic lung conditions like COPD, cystic fibrosis, bronchiectasis, or interstitial lung disease. It’s designed to learn more about these illnesses and to develop better ways to study or improve care.
This trial is testing a new targeted pill (luvometinib) alone or with another drug (cytarabine) for people with Langerhans cell histiocytosis that needs whole-body treatment. The goal is to see if the new approach can shrink or control the disease.
This study follows adults who have findings that suggest HLH, a serious immune problem. It may help doctors better understand the condition by tracking patients over time and comparing symptoms and test results.
This study looks at lung tissue from surgery to learn how pulmonary hypertension (high blood pressure in the lungs) develops in people with lung disease. The goal is to find better ways to diagnose and treat this condition.
Hear when a new Histiocytosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.